OncoMed Pharmaceuticals Inc (OMED) has 74 open-market insider trades by 22 insiders since 2013. The most active filer is Denise Pollard-Knight, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Deepika Pakianathan | Dir | — | 2 | $8.0M | 2019-04-23 |
| Denise Pollard-Knight | Dir | — | 9 | $5.1M | 2014-12-31 |
| Jonathan D. Root | Dir | — | 6 | $3.4M | 2019-04-23 |
| Management Group Viii L. L. C. Presidio | 10% | — | 2 | $3.4M | 2014-08-08 |
| Irwin Federman | 10% | — | 1 | $2.7M | 2013-07-23 |
| Life Science Ventures Ii L.p. Lvp | 10% | — | 1 | $1.5M | 2013-07-23 |
| James N. Woody | Dir10% | — | 1 | $1.5M | 2013-07-23 |
| James W. Broderick | Dir | — | 1 | $1.2M | 2013-07-23 |
| Partners Vii Lp Morgenthaler | 10% | — | 1 | $1.2M | 2013-07-23 |
| Entrepreneur Partners Viii A. L. P. Usvp | 10% | — | 1 | $1.0M | 2014-05-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Austin Gurney | — | Sell | $7K | 2018-12-24 |
| Robert Stagg | SVP & Clinical R&D | Sell | $2K | 2018-10-10 |
| Austin Gurney | — | Sell | $2K | 2018-10-10 |
| Alicia J. Hager | SVP & General Counsel | Sell | $2K | 2018-10-10 |
| Yvonne Li | — | Sell | $2K | 2018-10-10 |
| John A. Lewicki | President | Sell | $5K | 2018-10-09 |
Companies that share insiders with OMED, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Yvonne Li | — | Sell | $3K | 2018-10-09 |
| Alicia J. Hager | SVP & General Counsel | Sell | $4K | 2018-10-09 |
| Yvonne Li | — | Sell | $14K | 2018-04-24 |
| Robert Stagg | SVP & Clinical R&D | Sell | $11K | 2018-04-24 |
| John A. Lewicki | President | Sell | $12K | 2018-04-24 |
| Austin Gurney | — | Sell | $5K | 2017-10-10 |
| John A. Lewicki | EVP & Research & Development | Sell | $5K | 2017-10-10 |
| Paul J. Hastings | Chairman | Sell | $6K | 2017-10-10 |
| Perry A. Karsen | Director | Buy | $35K | 2017-06-05 |